1. Home
  2. Labeler Index
  3. Hf Acquisition Co. Llc, Dba Health First
  4. 51662-1201
  5. NDC Package Code: 51662-1201-1 Adenosine Injection, 6mg/2ml (3mg/ml) Vial

NDC Package 51662-1201-1 Adenosine Injection, 6mg/2ml (3mg/ml) Vial

View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing certification is expired.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
51662-1201-1
Package Description:
2 mL in 1 VIAL
Product Code:
51662-1201
Proprietary Name:
Adenosine Injection, 6mg/2ml (3mg/ml) Vial
Usage Information:
Adenosine injection is indicated for the following.Conversion to sinus rhythm of paroxysmal supraventricular tachycardia (PSVT), including that associated with accessory bypass tracts (Wolff-Parkinson-White Syndrome). When clinically advisable, appropriate vagal maneuvers (e.g., Valsalva maneuver), should be attempted prior to adenosine administration.It is important to be sure the adenosine solution actually reaches the systemic circulation ( See Dosage and Administration) Adenosine does not convert atrial flutter, atrial fibrillation, or ventricular tachycardia to normal sinus rhythm. In the presence of atrial flutter or atrial fibrillation, a transient modest slowing of ventricular response may occur immediately following adenosine administration.
11-Digit NDC Billing Format:
51662120101
NDC to RxNorm Crosswalk:
Labeler Name:
Hf Acquisition Co. Llc, Dba Health First
Sample Package:
No
FDA Application Number:
ANDA078076
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
07-14-2018
Listing Expiration Date:
12-31-2025
Exclude Flag:
E
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 51662-1201-1?

The NDC Packaged Code 51662-1201-1 is assigned to a package of 2 ml in 1 vial of Adenosine Injection, 6mg/2ml (3mg/ml) Vial, labeled by Hf Acquisition Co. Llc, Dba Health First. The product's dosage form is and is administered via form.

Is NDC 51662-1201 included in the NDC Directory?

No, Adenosine Injection, 6mg/2ml (3mg/ml) Vial with product code 51662-1201 is excluded from the NDC Directory for failure to respond to FDA's requests for correction to deficient or non-compliant submissions. The product was first marketed by Hf Acquisition Co. Llc, Dba Health First on July 14, 2018 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 51662-1201-1?

The 11-digit format is 51662120101. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-151662-1201-15-4-251662-1201-01